Tissue Banking Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Tissue Banking Market is Segmented By Product (Equipment, and Media and Consumables), Application, and Geography

Tissue Banking Market Snapshot

Tissue Banking Market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: >5.83 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Certain factors that are driving the market growth include rising healthcare expenditure, growing burden of chronic diseases and advances in drug discovery and development. The burden of chronic diseases is increasing worldwide. According to WHO, chronic diseases have always been a massive global challenge, and they account for approximately 60% of all deaths worldwide. The global burden of chronic diseases is expected to reach 57%, by 2020. This trend is expected to affect the emerging countries the most, as population growth is anticipated to be most significant in developing areas. Consequently, rising burden of chronic diseases is expected to drive the overall growth of the tissue banking market. However, stringent regulatory scenario is expected to restrain the growth of the global market in the forecast period.

Scope of the Report

As per the scope of the report, Tissue banks facilitate the collection and banking of human tissues. These tissues play an important role in many applications associated with healthcare. The market is being studied in three different aspects as follows:

By Product
Cryopreservation Equipment
Thawing Equipment
Quality Control Equipment
Media and Consumables
By Application
Medical Research
Other Applications
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East & Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Equipment Segment is Expected to Show Better Growth in the Forecast Period

Based on the product, it is segmented into equipment and media and consumables. The equipment segment is expected to grow at a faster pace during the forecast period. The key factor contributing to the growth of the segment is mainly driven by growing research activities and increasing the focus of market players on product development, along with the rising burden of chronic diseases. According to the World Health Organization (WHO), the four major chronic diseases which include cardiovascular diseases followed by cancer, respiratory diseases and diabetes account for most deaths. Factors, such as the aging population, lifestyles changes, leads to long-term health problems, and their treatment can be expensive. Additionally, Increasing government initiatives and rising demand for transplantation is expected to boost the studied market.

Tissue Banking Market

North America is Estimated to Account for the Largest Share in the Tissue Banking Market

North America holds a major share in the global tissue banking market, and it is expected to show a similar trend over the forecast period, without significant fluctuations. The United States market is driven by increasing R&D activities, along with rising burden of chronic diseases. According to Center for Disease Control and Prevention (CDC), 6 in 10 adults in the United States have a chronic disease. Different pharmaceutical/ biotech companies, academia, and research institutes are utilizing tissue banks for the storage of various sample. Hence, North America region is expected to grow at a faster rate due to rising preclinical activities by pharmaceutical companies, and growing research in this region.

Tissue Banking Market 2

Competitive Landscape

The leading players in the tissue banking market are AMS Biotechnology (Europe) Limited, Avantor, Inc (VWR International), BioCision LLC, Brooks Automation, Custom Biogenic Systems, Eppendorf AG, Hamilton Company, Merck KGaA and Thermo Fisher Scientific, Inc.

Recent Developments


Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Healthcare Expenditure

      2. 4.2.2 Growing Burden of Chronic Diseases

      3. 4.2.3 Technological Advances in Drug Discovery and Development

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulatory Scenario

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product

      1. 5.1.1 Equipment

        1. Cryopreservation Equipment

        2. Thawing Equipment

        3. Quality Control Equipment

        4. Others

      2. 5.1.2 Media and Consumables

    2. 5.2 By Application

      1. 5.2.1 Therapeutics

      2. 5.2.2 Medical Research

      3. 5.2.3 Other Applications

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle-East & Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 AMS Biotechnology (Europe) Limited

      2. 6.1.2 Avantor, Inc (VWR International)

      3. 6.1.3 Sartorius AG

      4. 6.1.4 Brooks Lifesciences (Brooks Automation Inc.)

      5. 6.1.5 Bio-Rad Laboratories Inc.

      6. 6.1.6 Eppendorf AG

      7. 6.1.7 Hamilton Company

      8. 6.1.8 Merck KGaA

      9. 6.1.9 Thermo Fisher Scientific, Inc.

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Tissue Banking Market market is studied from 2018 - 2026.

The Tissue Banking Market is growing at a CAGR of >5.83% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Avantor, Inc., Brooks Automation, Inc., Eppendorf AG, Merck KGaA, Thermo Fisher Scientific, Inc. are the major companies operating in Tissue Banking Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!